Novel Antithrombotic Agents: Indirect Synthetic Inhibitors of Factor Xa and Direct Thrombin Inhibitors. Evidences from Clinical Studies

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 2, Iss. 4, 2004-10 ,pp. : 311-326

Bentham Science Publishers

Access to resources Recommend Favorite

Synthetic Inhibitors of Thrombin and Factor Xa - What tests and if so why?

By Hauptmann J.   Sturzebecher J.  

Thrombosis Research, Vol. 93, Iss. 5, 1999-03 ,pp. : 203-241

Elsevier

Access to resources Recommend Favorite

Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor

By Becker Richard  

Journal of Thrombosis and Thrombolysis, Vol. 32, Iss. 2, 2011-08 ,pp. : 183-187

Springer Publishing Company

Access to resources Recommend Favorite

Factor Xa Inhibitors in Acute Coronary Syndromes and Venous Thromboembolism

By  

Current Vascular Pharmacology, Vol. 8, Iss. 1, 2010-01 ,pp. : 5-11

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor

By Wong Pancras  

Journal of Thrombosis and Thrombolysis, Vol. 31, Iss. 4, 2011-05 ,pp. : 478-492

Springer Publishing Company

Access to resources Recommend Favorite